As of December 2024, NeoGenomics has a market cap of $2.09B. This makes NeoGenomics the world's 4913th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.90B | -7.63% |
2023 | $2.06B | 75.11% |
2022 | $1.18B | -72.92% |
2021 | $4.35B | -36.63% |
2020 | $6.86B | 84.07% |
2019 | $3.73B | 131.96% |
2018 | $1.61B | 42.33% |
2017 | $1.13B | 3.38% |
2016 | $1.09B | 8.89% |
2015 | $1.00B | 88.73% |
2014 | $531.53M | 15.19% |
2013 | $461.43M | 45.97% |
2012 | $316.12M | 77.14% |
2011 | $178.45M | 7.69% |
2010 | $165.71M | -13.33% |
2009 | $191.20M | 145.90% |
2008 | $77.75M | -43.52% |
2007 | $137.66M | -28.00% |
2006 | $191.20M | 689.47% |
2005 | $24.22M | -24.00% |
2004 | $31.87M | - |